Type 2 diabetes and metabolic syndrome: identification of the molecular mechanisms, key signaling pathways and transcription factors aimed to reveal new therapeutical targets

Type 2 diabetes mellitus (T2DM) is a socially important disease with only symptomatic therapy developed due to lack of knowledge about its pathogenesis and underlying mechanism. Insulin resistance (IR) is the first link of T2DM pathogenesis and results in decrease of ability of insulin to stimulate...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ivan I. Dedov, Vsevolod A. Tkachuk, Nikolai B. Gusev, Vladimir P. Shirinsky, Aleksandr V. Vorotnikov, Tatiana N. Kochegura, Aleksander Y. Mayorov, Marina V. Shestakova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2018
Materias:	insulin resistance diabetes mellitus hyperglycaemia metabolic syndrome brown fat "beige" adipocytes insulin oxidative stress molecular mechanisms pkb/akt prep1 pparγ, small heat shock proteins endothelial dysfunction Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/5c1738b3a0bc4182853b0ade8b934222
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5c1738b3a0bc4182853b0ade8b934222
record_format	dspace
spelling	oai:doaj.org-article:5c1738b3a0bc4182853b0ade8b9342222021-11-14T09:00:21ZType 2 diabetes and metabolic syndrome: identification of the molecular mechanisms, key signaling pathways and transcription factors aimed to reveal new therapeutical targets2072-03512072-037810.14341/DM9730https://doaj.org/article/5c1738b3a0bc4182853b0ade8b9342222018-11-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/9730https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Type 2 diabetes mellitus (T2DM) is a socially important disease with only symptomatic therapy developed due to lack of knowledge about its pathogenesis and underlying mechanism. Insulin resistance (IR) is the first link of T2DM pathogenesis and results in decrease of ability of insulin to stimulate glucose uptake by target cells. Development of IR involves genetic predisposition, excessive nutrition, stress, obesity or chronic inflammation due to disruption of insulin signaling within cells. Molecular mechanisms and markers of IR are characterized rather poorly, which prevents early diagnosis and creation of preventive therapy. Euglycemic clamp test is still a golden standard for IR diagnosis in clinic. Hyperglycemia is a distant consequence of IR in which damaging effect of oxidative and carbonyl stress is realized and diagnosis of T2DM is stipulated. Molecular chaperones and small heat-shock proteins have a protective effect at the early stages of T2DM pathogenesis, preventing development of reticulum stress and apoptosis. Endothelial dysfunction is related to T2DM and its cardiovascular complications, however, it is unknown on which stage of pathogenesis these changes occur and what are their molecular inductors. Finally, transcriptional activity and adipogenic differentiation play an important role in formation of new fat depots from predecessor cells and activation of brown and “beige” fat demonstrating hypolipidemic and hypoglycemic properties. The aim of this study was investigation of pathophysiological mechanisms of development of IR and endothelial dysfunction, role of transcription factor Prep1 and small heat shock proteins, evaluation of novel methods of diagnostics of IR and therapeutic potential of brown and “beige” fat, determination of biotargets for new antidiabetic drugs.Ivan I. DedovVsevolod A. TkachukNikolai B. GusevVladimir P. ShirinskyAleksandr V. VorotnikovTatiana N. KocheguraAleksander Y. MayorovMarina V. ShestakovaEndocrinology Research Centrearticleinsulin resistancediabetes mellitushyperglycaemiametabolic syndromebrown fat"beige" adipocytesinsulinoxidative stressmolecular mechanismspkb/aktprep1pparγ, small heat shock proteinsendothelial dysfunctionNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 21, Iss 5, Pp 364-375 (2018)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	insulin resistance diabetes mellitus hyperglycaemia metabolic syndrome brown fat "beige" adipocytes insulin oxidative stress molecular mechanisms pkb/akt prep1 pparγ, small heat shock proteins endothelial dysfunction Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	insulin resistance diabetes mellitus hyperglycaemia metabolic syndrome brown fat "beige" adipocytes insulin oxidative stress molecular mechanisms pkb/akt prep1 pparγ, small heat shock proteins endothelial dysfunction Nutritional diseases. Deficiency diseases RC620-627 Ivan I. Dedov Vsevolod A. Tkachuk Nikolai B. Gusev Vladimir P. Shirinsky Aleksandr V. Vorotnikov Tatiana N. Kochegura Aleksander Y. Mayorov Marina V. Shestakova Type 2 diabetes and metabolic syndrome: identification of the molecular mechanisms, key signaling pathways and transcription factors aimed to reveal new therapeutical targets
description	Type 2 diabetes mellitus (T2DM) is a socially important disease with only symptomatic therapy developed due to lack of knowledge about its pathogenesis and underlying mechanism. Insulin resistance (IR) is the first link of T2DM pathogenesis and results in decrease of ability of insulin to stimulate glucose uptake by target cells. Development of IR involves genetic predisposition, excessive nutrition, stress, obesity or chronic inflammation due to disruption of insulin signaling within cells. Molecular mechanisms and markers of IR are characterized rather poorly, which prevents early diagnosis and creation of preventive therapy. Euglycemic clamp test is still a golden standard for IR diagnosis in clinic. Hyperglycemia is a distant consequence of IR in which damaging effect of oxidative and carbonyl stress is realized and diagnosis of T2DM is stipulated. Molecular chaperones and small heat-shock proteins have a protective effect at the early stages of T2DM pathogenesis, preventing development of reticulum stress and apoptosis. Endothelial dysfunction is related to T2DM and its cardiovascular complications, however, it is unknown on which stage of pathogenesis these changes occur and what are their molecular inductors. Finally, transcriptional activity and adipogenic differentiation play an important role in formation of new fat depots from predecessor cells and activation of brown and “beige” fat demonstrating hypolipidemic and hypoglycemic properties. The aim of this study was investigation of pathophysiological mechanisms of development of IR and endothelial dysfunction, role of transcription factor Prep1 and small heat shock proteins, evaluation of novel methods of diagnostics of IR and therapeutic potential of brown and “beige” fat, determination of biotargets for new antidiabetic drugs.
format	article
author	Ivan I. Dedov Vsevolod A. Tkachuk Nikolai B. Gusev Vladimir P. Shirinsky Aleksandr V. Vorotnikov Tatiana N. Kochegura Aleksander Y. Mayorov Marina V. Shestakova
author_facet	Ivan I. Dedov Vsevolod A. Tkachuk Nikolai B. Gusev Vladimir P. Shirinsky Aleksandr V. Vorotnikov Tatiana N. Kochegura Aleksander Y. Mayorov Marina V. Shestakova
author_sort	Ivan I. Dedov
title	Type 2 diabetes and metabolic syndrome: identification of the molecular mechanisms, key signaling pathways and transcription factors aimed to reveal new therapeutical targets
title_short	Type 2 diabetes and metabolic syndrome: identification of the molecular mechanisms, key signaling pathways and transcription factors aimed to reveal new therapeutical targets
title_full	Type 2 diabetes and metabolic syndrome: identification of the molecular mechanisms, key signaling pathways and transcription factors aimed to reveal new therapeutical targets
title_fullStr	Type 2 diabetes and metabolic syndrome: identification of the molecular mechanisms, key signaling pathways and transcription factors aimed to reveal new therapeutical targets
title_full_unstemmed	Type 2 diabetes and metabolic syndrome: identification of the molecular mechanisms, key signaling pathways and transcription factors aimed to reveal new therapeutical targets
title_sort	type 2 diabetes and metabolic syndrome: identification of the molecular mechanisms, key signaling pathways and transcription factors aimed to reveal new therapeutical targets
publisher	Endocrinology Research Centre
publishDate	2018
url	https://doaj.org/article/5c1738b3a0bc4182853b0ade8b934222
work_keys_str_mv	AT ivanidedov type2diabetesandmetabolicsyndromeidentificationofthemolecularmechanismskeysignalingpathwaysandtranscriptionfactorsaimedtorevealnewtherapeuticaltargets AT vsevolodatkachuk type2diabetesandmetabolicsyndromeidentificationofthemolecularmechanismskeysignalingpathwaysandtranscriptionfactorsaimedtorevealnewtherapeuticaltargets AT nikolaibgusev type2diabetesandmetabolicsyndromeidentificationofthemolecularmechanismskeysignalingpathwaysandtranscriptionfactorsaimedtorevealnewtherapeuticaltargets AT vladimirpshirinsky type2diabetesandmetabolicsyndromeidentificationofthemolecularmechanismskeysignalingpathwaysandtranscriptionfactorsaimedtorevealnewtherapeuticaltargets AT aleksandrvvorotnikov type2diabetesandmetabolicsyndromeidentificationofthemolecularmechanismskeysignalingpathwaysandtranscriptionfactorsaimedtorevealnewtherapeuticaltargets AT tatianankochegura type2diabetesandmetabolicsyndromeidentificationofthemolecularmechanismskeysignalingpathwaysandtranscriptionfactorsaimedtorevealnewtherapeuticaltargets AT aleksanderymayorov type2diabetesandmetabolicsyndromeidentificationofthemolecularmechanismskeysignalingpathwaysandtranscriptionfactorsaimedtorevealnewtherapeuticaltargets AT marinavshestakova type2diabetesandmetabolicsyndromeidentificationofthemolecularmechanismskeysignalingpathwaysandtranscriptionfactorsaimedtorevealnewtherapeuticaltargets
_version_	1718429529382322176

Type 2 diabetes and metabolic syndrome: identification of the molecular mechanisms, key signaling pathways and transcription factors aimed to reveal new therapeutical targets

Ejemplares similares